The University of Chicago Header Logo

Connection

Stephanie Mehlis to Alopecia Areata

This is a "connection" page, showing publications Stephanie Mehlis has written about Alopecia Areata.
Connection Strength

0.227
  1. Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study. J Eur Acad Dermatol Venereol. 2025 Jun; 39(6):1152-1162.
    View in: PubMed
    Score: 0.227
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.